Clinical Trial

The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Most patients with glaucoma use eye drops to lower their intraocular pressure. However, poor adherence to prescribed eye drop regimens can lead to significant loss of vision-related quality of life. This study will test the iDrop Device (iD2), a device-on-cap electronic platform monitor designed to accurately track when a research participant removes an eye drop bottle cap, wirelessly communicate usage data to a database accessible to researchers, and send on-demand alerts when a medication is due. A device capable of tracking eye drop usage and sending dosage alerts will test the hypothesis that electronic reminders improve medication adherence and help research subjects improve their eye drop taking behavior. While our primary focus is on glaucoma adherence, this device could also benefit those with other chronic eye conditions requiring regular eye drop treatment, such as dry eye, corneal endothelial disease, eye infections, and uveitis.
Trial Details
NCT Number NCT07664943
Lead Sponsor Universal Adherence LLC
Collaborators: National Eye Institute (NEI), National Institutes of Health (NIH)
Conditions Glaucoma, Medication Adherence
Enrollment 100 participants
Start Date 2026-09-01
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-24